Dermapharm Holding SE is a leading German pharmaceutical company specializing in the manufacture and distribution of off-patent branded pharmaceuticals and other healthcare products. Founded in 1991 b... Dermapharm Holding SE is a leading German pharmaceutical company specializing in the manufacture and distribution of off-patent branded pharmaceuticals and other healthcare products. Founded in 1991 by Wilhelm Beier and headquartered in Grünwald near Munich, it operates an integrated business model encompassing in-house product development, production, quality management, and sales through a dedicated pharmaceutical sales force. The company functions across three key segments: Branded Pharmaceuticals, featuring over 1,300 marketing authorizations with more than 390 active ingredients focused on dermatology, allergology, pain management, cardiovascular health, gynecology, and urology; Other Healthcare Products, including food supplements, herbal extracts, cosmetics, medical devices, and medicinal cannabis; and Parallel Import Business under the axicorp brand, importing originator drugs from EU states for resale in Germany. Notable brands include Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm. With production sites in Brehna and international operations in Europe, the US, and beyond, Dermapharm drives growth through R&D, strategic acquisitions like Euromed and Arkopharma, and market expansion, solidifying its role as a market leader in niche therapeutic areas.
Energy Management data not yet covered for Dermapharm Holding
We have not yet reviewed Dermapharm Holding's disclosures for Energy Management data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.